Tempus AI (NASDAQ:TEM) Shares Up 5.4% – Should You Buy?

Tempus AI, Inc. (NASDAQ:TEM) shares shot up 5.4% on Friday . The stock traded as high as $36.20 and last traded at $36.10. 945,839 shares changed hands during trading, a decline of 52% from the average session volume of 1,990,661 shares. The stock had previously closed at $34.25.

Analyst Ratings Changes

A number of equities analysts have weighed in on TEM shares. Stifel Nicolaus lowered Tempus AI from a “buy” rating to a “hold” rating and lifted their price objective for the company from $45.00 to $65.00 in a research note on Monday, November 11th. Guggenheim started coverage on Tempus AI in a report on Monday, December 9th. They issued a “buy” rating and a $74.00 price target for the company. Wolfe Research assumed coverage on Tempus AI in a research report on Friday, December 13th. They issued an “outperform” rating and a $60.00 price objective on the stock. Piper Sandler reaffirmed a “neutral” rating and set a $70.00 target price (up from $40.00) on shares of Tempus AI in a report on Tuesday, November 12th. Finally, Bank of America increased their price target on shares of Tempus AI from $52.00 to $54.00 and gave the stock a “neutral” rating in a report on Friday, December 13th. Three equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to MarketBeat, Tempus AI presently has a consensus rating of “Moderate Buy” and an average target price of $56.00.

Tempus AI Stock Up 11.7 %

The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17. The stock’s 50-day simple moving average is $48.93 and its two-hundred day simple moving average is $46.74.

Insider Buying and Selling

In other news, Director David R. Epstein sold 620 shares of the company’s stock in a transaction on Wednesday, December 11th. The shares were sold at an average price of $41.81, for a total transaction of $25,922.20. Following the completion of the sale, the director now owns 27,894 shares of the company’s stock, valued at $1,166,248.14. This represents a 2.17 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Eric P. Lefkofsky sold 187,655 shares of the firm’s stock in a transaction dated Wednesday, December 18th. The stock was sold at an average price of $37.54, for a total transaction of $7,044,568.70. Following the completion of the transaction, the chief executive officer now directly owns 9,557,283 shares in the company, valued at approximately $358,780,403.82. This represents a 1.93 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 845,041 shares of company stock worth $35,125,473 in the last 90 days.

Institutional Trading of Tempus AI

Large investors have recently bought and sold shares of the business. Franklin Resources Inc. boosted its stake in Tempus AI by 1.0% during the third quarter. Franklin Resources Inc. now owns 811,311 shares of the company’s stock worth $45,920,000 after buying an additional 8,387 shares during the last quarter. Tidal Investments LLC purchased a new position in shares of Tempus AI during the 3rd quarter worth $7,633,000. Teachers Retirement System of The State of Kentucky raised its holdings in shares of Tempus AI by 6.3% during the 3rd quarter. Teachers Retirement System of The State of Kentucky now owns 126,500 shares of the company’s stock worth $7,160,000 after acquiring an additional 7,500 shares during the period. Geode Capital Management LLC boosted its position in shares of Tempus AI by 0.4% during the 3rd quarter. Geode Capital Management LLC now owns 133,171 shares of the company’s stock valued at $7,537,000 after acquiring an additional 539 shares during the last quarter. Finally, XTX Topco Ltd purchased a new stake in shares of Tempus AI in the third quarter valued at about $502,000. Hedge funds and other institutional investors own 24.22% of the company’s stock.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.